Our results are in validation of two small clinical studies, where elevated EN-RAGE plasma protein levels (n = 171) [18] and S100A12 mRNA isolated from peripheral blood were associated with unfavorable 3-month functional outcome after stroke [19]. This evidence concerns the gene S100A12 and stroke disorder.